Researchers Information System

日本語に切り替えるswitch to english

Nishikawa, Hiroyoshi

Graduate School of Medicine Professor

Nishikawa, Hiroyoshi
list
    Last Updated :2026/07/29

    Basic Information

    Faculty

    • Faculty of Medicine

    Email Address

    • Email Address

      nishikawa.hiroyoshi.3nkyoto-u.ac.jp

    Academic Degree

    • 25 Mar. 2002
      三重大学博士(医学)

    Academic Resume (Graduate Schools)

    • 三重大学, 大学院医学系研究科博士課程内科系専攻, 修了

    Academic Resume (Undergraduate School/Majors)

    • 三重大学, 医学部医学科, 卒業
    list
      Last Updated :2026/07/29

      Research

      Awards

      • 07 Dec. 2022
        日本免疫学会ヒト免疫研究賞
      • 03 Dec. 2022
        安田医学賞(公益財団法人安田記念医学財団)
      • 14 Nov. 2020
        Society for Immunotherapy of Cancer (SITC),Team Science Award
      • 11 Mar. 2024
        上原賞(公益財団法人上原記念生命科学財団)
      • 12 Dec. 2023
        SGH特別賞(公益財団法人SGH財団)
      • 30 Sep. 2017
        JCA-Mauvernay Award(一般社団法人日本癌学会)
      • 30 Sep. 2006
        日本癌学会奨励賞
      • 01 Oct. 2022
        JCA-永山賞(一般社団法人日本癌学会)
      • 20 Apr. 2022
        文部科学大臣表彰科学技術賞 (研究部門)
      • 02 Nov. 2020
        American Association for the Advancement of Science (AAAS),Elected Fellow
      • 22 Feb. 2023
        高松宮妃癌研究基金学術賞
      • 17 Jun. 2023
        小林がん学術賞(公益財団法人小林がん学術振興会)
      list
        Last Updated :2026/07/29

        Education

        Participation in PhD Defense

        • Anti-PD-1 antibodies recognizing the membrane-proximal region are PD-1 agonists that can down-regulate inflammatory diseases
          SUZUKI KENSUKE, Graduate School of Medicine, Sub-chief Examiner
          23 May 2025
        • Identification of anti-mouse PD-1 agonist antibodies that inhibit T cell activation
          LIU LINGLING, Graduate School of Medicine, Sub-chief Examiner
          23 Mar. 2026
        • Beneficial effects on T cells by photodynamic therapy with talaporfin enhance cancer immunotherapy
          Ehab Mohemad Ezzaldeen Mahmoud, Graduate School of Medicine, Sub-chief Examiner
          23 May 2025
        • Blocking S100A9-signaling is detrimental to the initiation of anti-tumor immunity
          MELIKE FUSUN DEMIR, Graduate School of Medicine, Sub-chief Examiner
          24 Mar. 2025
        list
          Last Updated :2026/07/29

          Administration

          Faculty management (title, position)

          • がん免疫総合研究センター運営委員会_委員

          ページ上部へ戻る